- More than 9.5 million people have signed up for 2015 individual health insurance on the new exchanges created under the national healthcare reform law, the U.S. government said on Tuesday, a number that surpasses its enrollment target for the year.
BANGKOK (Thomson Reuters Foundation) - The Asia-Pacific region will not meet the goal of ending the HIV epidemic in 15 years unless it changes laws and attitudes hostile to people living with HIV, the head of the United Nations agency on AIDS said on Wednesday.
NEW YORK - President Barack Obama's plan to put the United States at the forefront of individually tailored medical treatment should give a much-needed boost to research in the field but experts say it won't work without reforms to healthcare, including drug testing and insurance.
ZURICH - Swiss drugmaker Roche expects sales and profits to grow at a similar pace to last year, after a strong performance by its diagnostics unit and flu drug Tamiflu helped full-year sales beat expectations.
WASHINGTON - Indiana on Tuesday became the 28th U.S. state to agree to expand the Medicaid program for the poor under President Barack Obama's healthcare reform law, a move that will extend health coverage to 350,000 low-income state residents, the administration said.
BERLIN - International donors pledged $7.5 billion on Tuesday to immunize 300 million children in poor countries against deadly diseases such as diarrhea and pneumonia.
- Laboratory testing company Quest Diagnostics Inc said on Tuesday it had signed a $520,000 agreement with the Centers for Disease Control and Prevention to identify trends in screening, diagnosis and treatment of four strains of viral hepatitis.
(This version of the Jan. 25th story corrects name and title of U.S. speaker in 6th paragraph)
LOS ANGELES - Doctors for student health centers at 10 University of California campuses staged a rare one-day strike on Tuesday, upset that administrators have failed to give their union information the physicians said they needed to negotiate their first contract.
- Medical device maker Abiomed Inc raised its full-year revenue forecast and said the U.S. Food and Drug Administration had approved its heart pump, sending its stock up about 30 percent in extended trading.